Buyse M - Search Results

1

Evaluation of surrogate endpoints in randomized experiments with mixed discrete and continuous outcomes.

Molenberghs G, Geys H, Buyse M. Molenberghs G, et al. Among authors: buyse m. Stat Med. 2001 Oct 30;20(20):3023-38. doi: 10.1002/sim.923. Stat Med. 2001. PMID: 11590630

2

Criteria for the validation of surrogate endpoints in randomized experiments.

Buyse M, Molenberghs G. Buyse M, et al. Biometrics. 1998 Sep;54(3):1014-29. Biometrics. 1998. PMID: 9840970

3

Statistical challenges in the evaluation of surrogate endpoints in randomized trials.

Molenberghs G, Buyse M, Geys H, Renard D, Burzykowski T, Alonso A. Molenberghs G, et al. Among authors: buyse m. Control Clin Trials. 2002 Dec;23(6):607-25. doi: 10.1016/s0197-2456(02)00236-2. Control Clin Trials. 2002. PMID: 12505240 Review.

4

A perspective on surrogate endpoints in controlled clinical trials.

Molenberghs G, Burzykowski T, Alonso A, Buyse M. Molenberghs G, et al. Among authors: buyse m. Stat Methods Med Res. 2004 Jun;13(3):177-206. doi: 10.1191/0962280204sm362ra. Stat Methods Med Res. 2004. PMID: 15198486

5

Prentice's approach and the meta-analytic paradigm: a reflection on the role of statistics in the evaluation of surrogate endpoints.

Alonso A, Molenberghs G, Burzykowski T, Renard D, Geys H, Shkedy Z, Tibaldi F, Abrahantes JC, Buyse M. Alonso A, et al. Among authors: buyse m. Biometrics. 2004 Sep;60(3):724-8. doi: 10.1111/j.0006-341X.2004.00222.x. Biometrics. 2004. PMID: 15339295

6

A unifying approach for surrogate marker validation based on Prentice's criteria.

Alonso A, Molenberghs G, Geys H, Buyse M, Vangeneugden T. Alonso A, et al. Among authors: buyse m. Stat Med. 2006 Jan 30;25(2):205-21. doi: 10.1002/sim.2315. Stat Med. 2006. PMID: 16220497

7

The validation of surrogate endpoints in meta-analyses of randomized experiments.

Buyse M, Molenberghs G, Burzykowski T, Renard D, Geys H. Buyse M, et al. Biostatistics. 2000 Mar;1(1):49-67. doi: 10.1093/biostatistics/1.1.49. Biostatistics. 2000. PMID: 12933525

8

A unified framework for the evaluation of surrogate endpoints in mental-health clinical trials.

Molenberghs G, Burzykowski T, Alonso A, Assam P, Tilahun A, Buyse M. Molenberghs G, et al. Among authors: buyse m. Stat Methods Med Res. 2010 Jun;19(3):205-36. doi: 10.1177/0962280209105015. Epub 2009 Jul 16. Stat Methods Med Res. 2010. PMID: 19608602 Review.

9

Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Meta-Analysis Group in Cancer.

Buyse M, Thirion P, Carlson RW, Burzykowski T, Molenberghs G, Piedbois P. Buyse M, et al. Lancet. 2000 Jul 29;356(9227):373-8. doi: 10.1016/s0140-6736(00)02528-9. Lancet. 2000. PMID: 10972369

10

Surrogate threshold effect: an alternative measure for meta-analytic surrogate endpoint validation.

Burzykowski T, Buyse M. Burzykowski T, et al. Among authors: buyse m. Pharm Stat. 2006 Jul-Sep;5(3):173-86. doi: 10.1002/pst.207. Pharm Stat. 2006. PMID: 17080751

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

470 results

Search Page

Filters